Cover Image

OA3-2 PD-1 blockade in 12 HIV-infected patients with lung cancer

Saved in:

Bibliographic Details
Main Authors:	A. Samri (Author), A. Lavolé (Author), S. Even (Author), S. Lambert-Niclot (Author), G. Le Garff (Author), J. Cadranel (Author), J. Spano (Author), A. Marcelin (Author), B. Autran (Author), A. Guihot (Author)
Format:	Book
Published:	Elsevier, 2017-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OA3-3 Anti-PD-1 disrupts HIV latency in non-proliferating but not in proliferating T cells
by: R.M. Van der Sluis, et al.
Published: (2017)

OA4-3 PD-1 blockade combined with ART improves SIV-specific CD8 T cell function and enhances control of pathogenic SIV after ART interruption
by: G.H. Mylvaganam, et al.
Published: (2016)

OA3-1 HIV reservoir dynamics and immune responses after anti-PD-1 therapy
by: E. Scully, et al.
Published: (2017)

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
by: Man Wang, et al.
Published: (2023)

Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?
by: Laura Jimbu, et al.
Published: (2021)

PD-1 blockade boost vaccine-induced anti-HIV responses in the absence of HIV reactivation
by: J.G. Prado, et al.
Published: (2019)

Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy
by: Chongzheng Yan, et al.
Published: (2024)

Blockade of PD-L1/PD-1 signaling promotes osteo-/odontogenic differentiation through Ras activation
by: So Mi Jeon, et al.
Published: (2022)

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
by: Jin-Yu Sun, et al.
Published: (2020)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
by: Mengjie Wang, et al.
Published: (2022)

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
by: Luisa Chocarro de Erauso, et al.
Published: (2020)

Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
by: Ge Y, et al.
Published: (2022)

Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations
by: Jiqiao Yang, et al.
Published: (2019)

Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer
by: Shiyun Chen, et al.
Published: (2023)

Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
by: Dan Zheng, et al.
Published: (2022)

Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides
by: Jérémie Delaleu, et al.
Published: (2024)

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
by: Mingxia Zhao, et al.
Published: (2019)

Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model
by: Weiqiu Jin, et al.
Published: (2023)

OA1-1 Unanticipated participant benefits in HIV cure clinical research: a qualitative analysis
by: A. Gilbertson, et al.
Published: (2016)

B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques
by: L.J. Picker, et al.
Published: (2019)

OP 1.10 - 00210 Clonal Dynamics within HIV-Infected CD4 T Cell Reservoirs after PD-1 Blockade under ART
by: L. Perez, et al.
Published: (2022)

OA16.04. Women's sources of information for CAM use during pregnancy
by: Frawley J, et al.
Published: (2012)

OA3-1 Allogeneic stem cell transplantation in HIV-1-infected individuals; the EPISTEM consortium
by: A.M. Wensing, et al.
Published: (2016)

Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix
by: Marie-Gabrielle Courtès, et al.
Published: (2024)

On The Blockade
by: Optic, Oliver, 1822-1897; Bridgman, L. J. (Lewis Jesse), 1857-1931 [Illustrator]

OA1-1 Impact of vorinostat treatment of non-Hodgkin's lymphoma on HIV-1 latent reservoir
by: A. Capoferri, et al.
Published: (2017)

PD-1 and PD-L1 expression in rare lung tumors
by: Marton Gyulai, et al.
Published: (2023)

OA12.04. The role of mind-body awareness in complementary and alternative medicine (CAM) outcomes
by: Sirois F, et al.
Published: (2012)

Uploading OA Books A manual
by: Snijder, Ronald
Published: (2021)

OA01.04. The effectiveness and cost effectiveness of acupressure for chemotherapy-related nausea
by: Hughes J, et al.
Published: (2012)

Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
by: Youngjoo Lee, et al.
Published: (2024)

Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome
by: Chuan Hu, et al.
Published: (2023)

OA02.04. Integrative Health Coaching: the accumulating research at Duke IM
by: Kosey J, et al.
Published: (2012)

OA13.03. Promoting safe and integrated maternity care through interprofessional education
by: Steel A, et al.
Published: (2012)

Blockade of PD-1 Signaling Enhances Th2 Cell Responses and Aggravates Liver Immunopathology in Mice with Schistosomiasis japonica.
by: Sha Zhou, et al.
Published: (2016)

Pheophorbide A-Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD-L1 Expression
by: Qinli Tong, et al.
Published: (2022)

PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model
by: Weimin Zhu, et al.
Published: (2013)

Impact of Salt Intake and RAAS blockade on lung SARS CoV-2 Host Factors
by: Xiaoli Zhang, et al.
Published: (2022)

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques
by: M. Mavigner, et al.
Published: (2016)

Foetal vascular responses to thromboxane receptor blockade
by: B. A. Meyer, et al.
Published: (1992)